Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erick H Turner

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Plos Medicine|March 24, 2005
Is it always unethical to use a placebo in a clinical trial?Andreas Stang, Hans-Werner Hense, Karl-Heinz Jöckel, et al.
Plos Medicine|January 19, 2022
Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trialsErick H Turner, Andrea Cipriani, Toshi A Furukawa, et al.
Plos One|October 1, 2015
Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded TrialsEllen Driessen, Steven D Hollon, Claudi L H Bockting, et al.
BMJ Open|April 1, 2017
Spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literatureLian Beijers, Bertus F Jeronimus, Erick H Turner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 24, 2016
Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: A meta-analysisYmkje Anna de Vries, Annelieke M Roest, Lian Beijers, et al.
BMJ (Clinical Research Ed.)|August 22, 2012
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional studyMichelle Roseman, Erick H Turner, Joel Lexchin, et al.
Plos One|April 9, 2016
Reporting of Positive Results in Randomized Controlled Trials of Mindfulness-Based Mental Health InterventionsStephanie Coronado-Montoya, Alexander W Levis, Linda Kwakkenbos, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 19, 2016
Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regressionYmkje Anna de Vries, Peter de Jonge, Edwin van den Heuvel, et al.
Systematic Reviews|April 10, 2020
Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009Carla Benea, Kimberly A Turner, Michelle Roseman, et al.
JAMA|March 10, 2011
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatmentsMichelle Roseman, Katherine Milette, Lisa A Bero, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Plos Medicine|March 24, 2005
Is it always unethical to use a placebo in a clinical trial?Andreas Stang, Hans-Werner Hense, Karl-Heinz Jöckel, et al.
Plos Medicine|January 19, 2022
Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trialsErick H Turner, Andrea Cipriani, Toshi A Furukawa, et al.
Plos One|October 1, 2015
Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded TrialsEllen Driessen, Steven D Hollon, Claudi L H Bockting, et al.
BMJ Open|April 1, 2017
Spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literatureLian Beijers, Bertus F Jeronimus, Erick H Turner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 24, 2016
Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: A meta-analysisYmkje Anna de Vries, Annelieke M Roest, Lian Beijers, et al.
BMJ (Clinical Research Ed.)|August 22, 2012
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional studyMichelle Roseman, Erick H Turner, Joel Lexchin, et al.
Plos One|April 9, 2016
Reporting of Positive Results in Randomized Controlled Trials of Mindfulness-Based Mental Health InterventionsStephanie Coronado-Montoya, Alexander W Levis, Linda Kwakkenbos, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 19, 2016
Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regressionYmkje Anna de Vries, Peter de Jonge, Edwin van den Heuvel, et al.
Systematic Reviews|April 10, 2020
Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009Carla Benea, Kimberly A Turner, Michelle Roseman, et al.
JAMA|March 10, 2011
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatmentsMichelle Roseman, Katherine Milette, Lisa A Bero, et al.
Pageof 4